Short Interest in Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Drops By 35.0%

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) was the target of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 130,922 shares, a decrease of 35.0% from the May 31st total of 201,477 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 48,613 shares, the days-to-cover ratio is currently 2.7 days.

Sernova Biotherapeutics Stock Performance

Shares of OTCMKTS SEOVF opened at $0.09 on Friday. The firm has a market cap of $35.50 million, a PE ratio of -2.35 and a beta of 0.82. The firm has a fifty day moving average of $0.11 and a 200 day moving average of $0.11. Sernova Biotherapeutics has a one year low of $0.07 and a one year high of $0.16.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last posted its quarterly earnings data on Thursday, June 11th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01).

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.